Pharma giant acquires consultancy to bolster regulatory affairs expertise
Global pharmaceuticals firm Clinigen has acquired Kinesys Consulting to boost its regulatory affairs knowledge.
The deal will fuel Burton-based Clinigen’s mission of accelerating the development and delivery of life-saving treatments to patients worldwide.
Clients will be guided by Kinesys through regulatory strategy and execution for drugs and medical devices, as well as having access to a high-quality medical/regulatory writing service
Pharmaceutical giant Clinigen was acquired by Triton Funds in 2022 in a £1.3bn deal an... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
